Pfizer has agreed to pay the federal government $60s million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales. The Securities and Exchange Commission says Pfizer’s subsidiaries overseas made illegal payments to health care officials in China, Italy, Russia, Croatia and other […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Digital Partnership, Silver Membership, Print & Digital, Print, Digital and The Transcript, Corporate Membership or Digital Monthly If you're already a member, sign in here.